Pancreatic Cancer Research

ResearcherBrown UniversityActive in the last 2 years

Katsuya Nagaoka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7152-6101; OpenAlex author ID A5005875682. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 6

  1. Corrigendum to "Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma" [Cancer Lett. 449 (2019) … Co-author DOI 10.1016/j.canlet.2025.218118↗
  2. Corrigendum to "Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis" [Cancer Lett. 481 (2020) 63-75]. Co-author DOI 10.1016/j.canlet.2025.218119↗
  3. Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasi… First author DOI 10.1007/s00535-024-02195-8↗
  4. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis. Co-author DOI 10.1016/j.canlet.2020.02.039↗
  5. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2019.02.006↗
  6. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Co-author DOI 10.1186/s13045-019-0837-z↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuewei Bai · 5 shared papers, 2019–2026 · strength 0.74
  2. Xiaoqun Dong · 5 shared papers, 2019–2026 · strength 0.74
  3. Jack R. Wands · 5 shared papers, 2019–2026 · strength 0.74
  4. Kosuke Ogawa · 5 shared papers, 2019–2026 · strength 0.74
  5. Qiushi Lin · 3 shared papers, 2019–2026 · strength 0.38
  6. Lianxin Liu · 3 shared papers, 2019–2026 · strength 0.38
  7. Rui Kong · 3 shared papers, 2019–2026 · strength 0.38
  8. Le Li · 3 shared papers, 2019–2026 · strength 0.38
  9. Howard P. Safran · 3 shared papers, 2019–2026 · strength 0.38
  10. Min Li · 2 shared papers, 2019–2026 · strength 0.30
  11. Yongwei Wang · 1 shared paper, 2026 · strength 0.22
  12. Naotaka Kugiyama · 1 shared paper, 2025 · strength 0.21
  13. Hiromitsu Hayashi · 1 shared paper, 2025 · strength 0.21
  14. Yasuhito Tanaka · 1 shared paper, 2025 · strength 0.21
  15. Hajime Yamazaki · 1 shared paper, 2025 · strength 0.21
  16. Takatsugu Ishimoto · 1 shared paper, 2025 · strength 0.21
  17. Yongwei Wang · 2 shared papers, 2019–2020 · strength 0.16
  18. Bei Sun · 1 shared paper, 2020 · strength 0.08
  19. Min Li · 1 shared paper, 2020 · strength 0.08
  20. Bei Sun · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.